Literature DB >> 33012678

Oxaliplatin-induced Immune Thrombocytopenia: A Case Report and Literature Review.

Anthony Stack1, Rashmi Khanal2, Crystal S Denlinger3.   

Abstract

Entities:  

Keywords:  Colorectal cancer; Drug reaction; FOLFOX; Gastrointestinal cancers; Hypersensitivity reaction

Mesh：

Substances：

Year:  2020        PMID： 33012678      PMCID： PMC7855550          DOI： 10.1016/j.clcc.2020.07.007

Source DB:  PubMed          Journal:  Clin Colorectal Cancer        ISSN： 1533-0028            Impact factor:   4.481


× No keyword cloud information.
  41 in total

1.  Allergic-type reactions to oxaliplatin: retrospective analysis of 42 patients.

Authors:  Frédérique Maindrault-Goebel; Thierry André; Christophe Tournigand; Christophe Louvet; Nathalie Perez-Staub; Nora Zeghib; Aimery De Gramont
Journal:  Eur J Cancer       Date:  2005-09-09       Impact factor: 9.162

2.  Oxaliplatin-mediated autoimmune thrombocytopenia.

Authors:  Muhammad Wasif Saif; Angeline The; Leslie Ledbetter
Journal:  Clin Colorectal Cancer       Date:  2009-01       Impact factor: 4.481

Review 3.  Drug-induced thrombocytopenia: a systematic review of published case reports.

Authors:  J N George; G E Raskob; S R Shah; M A Rizvi; S A Hamilton; S Osborne; T Vondracek
Journal:  Ann Intern Med       Date:  1998-12-01       Impact factor: 25.391

Review 4.  Clinical pharmacokinetics of oxaliplatin: a critical review.

Authors:  M A Graham; G F Lockwood; D Greenslade; S Brienza; M Bayssas; E Gamelin
Journal:  Clin Cancer Res       Date:  2000-04       Impact factor: 12.531

Review 5.  Oxaliplatin-induced immune-mediated cytopenias: a case report and literature review.

Authors:  Nicholas P Forcello; Sapna Khubchandani; Shrina J Patel; Driola Brahaj
Journal:  J Oncol Pharm Pract       Date:  2014-02-05       Impact factor: 1.809

6.  Acute immune hematological complication of oxaliplatin. A series of 3 cases.

Authors:  Sylvain Garciaz; Sandrine Oziel-Taieb; Slimane Dermeche; Pauline Ries; Julie Vessaud; Jean-Luc Raoul
Journal:  Tumori       Date:  2014 Jan-Feb       Impact factor: 2.098

7.  Hypersensitivity Reactions to oxaliplatin: incidence and management.

Authors:  Aruna Gowda; Ramil Goel; Joanne Berdzik; Cynthia G Leichman; Milind Javle
Journal:  Oncology (Williston Park)       Date:  2004-11       Impact factor: 2.990

8.  Can chemotherapy be discontinued in unresectable metastatic colorectal cancer? The GERCOR OPTIMOX2 Study.

Authors:  Benoist Chibaudel; Frédérique Maindrault-Goebel; Gérard Lledo; Laurent Mineur; Thierry André; Mostepha Bennamoun; May Mabro; Pascal Artru; Elisabeth Carola; Michel Flesch; Olivier Dupuis; Philippe Colin; Annette K Larsen; Pauline Afchain; Christophe Tournigand; Christophe Louvet; Aimery de Gramont
Journal:  J Clin Oncol       Date:  2009-09-28       Impact factor: 44.544

Review 9.  Oxaliplatin Immune-Induced Syndrome Occurs With Cumulative Administration and Rechallenge: Single Institution Series and Systematic Review Study.

Authors:  Katia Bencardino; Gianluca Mauri; Alessio Amatu; Federica Tosi; Erica Bonazzina; Laura Palmeri; Marialuisa Querques; Federica Ravera; Alberto Menegotto; Elisa Boiani; Andrea Sartore-Bianchi; Salvatore Siena
Journal:  Clin Colorectal Cancer       Date:  2016-02-19       Impact factor: 4.481

10.  Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

Authors:  Thierry André; Corrado Boni; Lamia Mounedji-Boudiaf; Matilde Navarro; Josep Tabernero; Tamas Hickish; Clare Topham; Marta Zaninelli; Philip Clingan; John Bridgewater; Isabelle Tabah-Fisch; Aimery de Gramont
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245
View more
  1 in total

1.  A severe oxaliplatin immune-induced syndrome after oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC).

Authors:  Anne-Cecile Ezanno; Brice Malgras; Olivier Aoun; Amaury Delarge; Alice Doreille; Marc Pocard
Journal:  Pleura Peritoneum       Date:  2022-01-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.